Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial.
Ann Oncol
; 27(11): 2074-2081, 2016 11.
Article
in En
| MEDLINE
| ID: mdl-27573560
Search on Google
Database:
MEDLINE
Main subject:
Antineoplastic Combined Chemotherapy Protocols
/
Colonic Neoplasms
/
Deoxycytidine
/
Fluorouracil
/
Neoplasm Recurrence, Local
Type of study:
Clinical_trials
Language:
En
Journal:
Ann Oncol
Year:
2016
Type:
Article